However, the neuropsychological group showed a significantly greater improvement on a line cancellation test of visual neglect ( t (62) = 2.1, P < 0.05) and a planned subanalysis for those with right hemisphere damage showed a trend towards better dressing outcome ( P = 0.07, one-tailed).
ASYMAD and CN did not show significant differences in the amount of tau, yet the ASYMAD group showed a trend toward greater tau in the MFG as compared with CN ( P = 0.07).
IL‐8 also showed a trend to be reduced on day 3 in the OZA group ( P = 0.07; Figure 3b ) and P‐ values are reported for other cytokines such as C–X–C motif ligand (CXCL) 13, interferon‐γ, tumor necrosis factor and IL‐6 (Figure 3c–f ; see Supplementary figure 3 for the remaining analytes).
The 10 METH abusers who remained abstinent showed a trend for lower baseline D2R availability (p < 0.07) and less MPH-induced DA release (treatment × diagnosis, p < 0.07) in caudate than the controls.
A higher level of education showed a trend toward a positive association (p = 0.07) with some physical indexes on the SF-36 questionnaire (PCS, PF, and BP).
Diary data confirmed the total number of migraine days/month (4.11 ± 2.8) and showed a trend to a higher frequency in group 1 ( p < 0.07).
In colorectal cancer, exon 9 PIK3CA mutations showed a trend towards increased frequency in patients with KRAS mutations (9/45; 20%) compared to patients with wt KRAS (3/46; 6%) (p = 0.07), whereas the frequency of exon 20 PIK3CA mutations did not significantly differ (4/40 [10%] in KRAS mutant vs. 2/45 [4%] in wt KRAS ; p = 0.4).
There was no difference in the overall response rate between the 9 or 18 μg/kg/day cohorts; however, a subset analysis of patients with stage IIB disease or higher, showed a trend towards higher response ( P = 0.07).
Concomitant use of cyclophosphamide significantly increased the risk of cardiac dysfunction ( P = 0.048), while low BMI (<20 kg/m 2 ) and preexisting cardiac disease showed a trend towards increased risk of cardiac dysfunction ( P = 0.07 for both).
Survival BMI groups showed a trend to predict survival in our study cohort (p = 0.07, Fig. 2 ).
Patients with increasing postoperative S-100B serum levels showed a trend toward statistical significance when correlated to DFS (HR 2.6, P = .07).
Presence of BCL2 and MYC mRNA in plasma showed a trend to significant association with partial response in patients with DLBCL ( p = 0.07 for both; χ 2 test; Table 1 ).
Results: HIIE and MICE showed a trend to decrease ghrelin levels immediately post-exercise (-14.1 ± 21.6% and −9.6 ± 23.8%, respectively, p = 0.07) and decreased 1h post-exercise (-12.7 ± 31.8% and −13.8 ± 21.7%, respectively, p < 0.05).
SOCS3 mRNA expression increased 6-fold at T24 (P<0.05) and showed a trend to remain elevated at T72 (p = 0.07) returning to baseline by T120 ( Fig. 5b ).
The changes in fruit intake in the treatment group following the intervention showed a trend toward statistical significance ( p = 0.07).
This polymorphism also showed a trend toward being associated with AML risk under the dominant model ( p = 0.07).
Longer time from diagnosis to RT showed a trend toward improved OS (p = 0.07).
These post-hoc comparisons also showed a trend that Remember trials were associated with increased frequency of subsequent information-seeking relative to Unfamiliar trials, p = 0.07.
conducted a multicenter retrospective study of 130 newly diagnosed older AML patients receiving HMA/venetoclax and found that while pre-existing CKD showed a trend toward lower overall response rates (OR: 0.5; p=0.07), it did not significantly affect overall survival; however, acute kidney injury during treatment was an independent prognostic factor for inferior overall survival (HR: 1.86; p=0.01) [ 15 ].
STZ administration showed a trend toward reduced mature BDNF content compared with the SHAM group ( p = 0.07), whereas combined VitD 3 and DMF treatment significantly increased mature BDNF content compared with the STZ group.
Low frequency gamma band activity was also significantly decreased for KO mice in wake during the dark period (2- tailed Mann Whitney U Test: z = 2.11, p = 0.03) and showed a trend level decrease during the light period (2- tailed Mann Whitney U Test: z = 1.79, p = 0.07).
Patients who developed thyroid irAEs showed a trend toward improved OS (log-rank p = 0.07; HR 0.45, 95% CI 0.19–1.08), which reached statistical significance after adjustment for predefined confounders (HR 0.40, 95% CI 0.17–0.98; p = 0.045).
Grafts with a GRWR < 0.8 showed a trend toward higher proportional growth (137% ± 55% vs. 110% ± 41%; p = 0.07 for parametric, p = 0.04 for non-parametric).
Patients with allergic side effects during the entire course of VIT showed a trend towards higher rApi m 5 values when compared to the group without allergic side effects: median [Q25–Q75] 0.41 [0.01–1.12] vs. 0.04 [0–0.50] p = 0.07 ( Table 7 ).
When stratified by sex, this study showed a trend toward higher sarcopenia prevalence in women with elevated TFAM levels, albeit this did not reach statistical significance ( p = 0.07).